Rapid detection of glycoprotein G gene for the diagnosis and typing of herpes simplex virus infection in genital herpes

被引:5
|
作者
Fang, XF
Song, B
Tu, YY
Tong, JZ
Faul, JL
Bai, H [1 ]
机构
[1] Sun Yat San Univ Med Sci, Dept Dermatovenereol, Affiliated Hosp 1, Guangzhou 510080, Peoples R China
[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
关键词
herpes simplex virus; genital herpes; polymerase chain reaction;
D O I
10.1136/sti.75.6.396
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To develop a new, rapid, and convenient technique for the diagnosis and typing of herpes simplex virus (HSV) in genital herpes (GH) Methods: Using samples from skin vesicle fluid and urogenital mucosal swabs of subjects with GH, conventional polymerase chain reaction (PCR) (directed to polymerase gene: PCRpG) were compared with a newly developed PCR (directed to HSV glycoprotein gene: PCRgG). Both PCR methods were compared with virus isolation culture (VI) with indirect immunofluorescent staining (IIF). Results: 80 samples from 40 GH patients (25 males) were tested. Positive results were seen in 52.5% (42/80) using PCRgG compared with 40% (32/80) by VI. Most of PCRgG positive samples (95.1%) were caused by HSV-2 infection. In samples from healing lesions, HSV was detected more often by PCRgG, than by VI. The results of typing by PCRgG and IIF:were highly consistent. Conclusion: PCRgG is more sensitive than VE and PCRpG in detecting HSV in urogenital samples from subjects with GH. PCRgG is a convenient technique for the rapid detection and typing of GH.
引用
收藏
页码:396 / 397
页数:2
相关论文
共 50 条
  • [1] Genital infection with herpes simplex virus
    Uuskula, A
    SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, 2001, : 321 - 328
  • [2] Genital herpes simplex virus infection
    Steben, M
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2005, 48 (04): : 838 - 844
  • [3] HERPES-SIMPLEX VIRUS GLYCOPROTEIN TREATMENT OF RECURRENT GENITAL HERPES
    STANBERRY, LR
    BURKE, RL
    MYERS, MG
    JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (01): : 156 - 163
  • [4] HERPES-SIMPLEX VIRUS GLYCOPROTEIN IMMUNOTHERAPY OF RECURRENT GENITAL HERPES
    STANBERRY, LR
    HARRISON, CJ
    BERNSTEIN, DI
    BURKE, RL
    MYERS, MG
    CLINICAL RESEARCH, 1988, 36 (03): : A471 - A471
  • [5] Diagnosis of genital herpes simplex virus infection in the clinical laboratory
    LeGoff, Jerome
    Pere, Helene
    Belec, Laurent
    VIROLOGY JOURNAL, 2014, 11
  • [6] Diagnosis of genital herpes simplex virus infection in the clinical laboratory
    Jérôme LeGoff
    Hélène Péré
    Laurent Bélec
    Virology Journal, 11
  • [7] Erratum to: Diagnosis of genital herpes simplex virus infection in the clinical laboratory
    Jérôme LeGoff
    Hélène Péré
    Laurent Bélec
    Virology Journal, 12
  • [8] Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate
    Büchner, S
    Erni, P
    Garweg, J
    Gerber, S
    Hirsch, HH
    Kempf, W
    Kind, C
    Lauper, U
    Lautenschlager, S
    Meylan, P
    Nadal, D
    Reusser, P
    SWISS MEDICAL WEEKLY, 2004, 134 (15-16) : 205 - 214
  • [9] Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection
    Onnheim, Karin
    Ekblad, Maria
    Gorander, Staffan
    Bergstrom, Tomas
    Liljeqvist, Jan-Ake
    VIRUSES-BASEL, 2016, 8 (04):
  • [10] Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig
    Bernstein, David I.
    Earwood, Julie D.
    Bravo, Fernando J.
    Cohen, Gary H.
    Eisenberg, Roselyn J.
    Clark, Jennifer R.
    Fairman, Jeffrey
    Cardin, Rhonda D.
    VACCINE, 2011, 29 (11) : 2071 - 2078